Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia

Advances in technology have made possible the prenatal diagnosis and treatment of female fetuses with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormonal measurement of 17-hydroxyprogesterone, androstenedione, testosterone and 21-deoxycortisol and HLA typing and DNA analysis for 21-OH/C4/HLA class I and II genes in chorionic villus cells and amniocytes are utilized for prenatal diagnosis. Maternal dexamethasone administration begun in the first trimester has prevented or ameliorated virilization in approximately three-fourths of infants. Maternal estriol levels appear to be the most accurate measure of fetal adrenal suppression. Maternal side effects are not infrequent and include excess weight gain, edema, glucose intolerance, hypertension and gastrointestinal problems. Severe permanent striae have been reported. Although no complications of prenatal treatment in the treated fetus or child have been reported long-term follow-up with careful neuropsychologic evaluation is not yet available and is necessary to fully evaluate possible long-term side-effects of prenatal dexamethasone treatment.

[1]  PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY , 1993, Pediatric Research.

[2]  M. Forest,et al.  PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY , 1993, Pediatric Research.

[3]  E. C. Neto,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder , 1993 .

[4]  M. Forest,et al.  Prenatal diagnosis and treatment of 21-hydroxylase deficiency , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  D. Shulman,et al.  Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. , 1992, The Journal of clinical endocrinology and metabolism.

[6]  P. White,et al.  Prenatal diagnosis/treatment in families at risk for infants with steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia) , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  P. White,et al.  First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). , 1990, The Journal of clinical endocrinology and metabolism.

[8]  L. Immken,et al.  Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1990, The New England journal of medicine.

[9]  E. Shapiro,et al.  Prenatal fetal adrenal suppression following in utero diagnosis of congenital adrenal hyperplasia. , 1989, The Journal of urology.

[10]  J. Fiet,et al.  Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid. , 1988, The Journal of clinical endocrinology and metabolism.

[11]  I. Hughes,et al.  Prenatal diagnosis of congenital adrenal hyperplasia: reliability of amniotic fluid steroid analysis. , 1987, Journal of medical genetics.

[12]  P. Betts,et al.  THE INTERPRETATION OF BLOODSPOT 17α -HYDROXYPROGESTERONE LEVELS IN TERM AND PRETERM NEONATES , 1986, Pediatric Research.

[13]  B. Hardy,et al.  Urinoma of the fallopian tube in virilizing congenital adrenal hyperplasia. , 1986, The Journal of pediatrics.

[14]  P. Betts,et al.  THE INTERPRETATION OF BLOODSPOT 17α -HYDROXYPROGESTERONE LEVELS IN TERM AND PRETERM NEONATES , 1986, Pediatric Research.

[15]  R. Nussbaum,et al.  Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. , 1985, Annals of the New York Academy of Sciences.

[16]  H. Dörr,et al.  117 PRENATAL TREATMENT OF A GIRL WITH 21-HYDROXYLASE DEFICIENCY (CAH) , 1985, Pediatric Research.

[17]  G. Chrousos,et al.  Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia. , 1985, JAMA.

[18]  M. Forest,et al.  Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. , 1984, The Journal of pediatrics.

[19]  E. Haan,et al.  Prenatal diagnosis and successful intrauterine treatment of a female fetus with 21‐hydroxylase deficiency , 1992, The Medical journal of Australia.

[20]  R. Odink,et al.  THE VALUE OF CHORION VILLUS SAMPLING IN EARLY DETECTION OF 21 HYDROXYLASE DEFICIENCY (21-OHD) , 1988, Pediatric Research.

[21]  T. Romer,et al.  Successful prenatal treatment of congenital adrenal hyperplasia resulting from the 21-hydroxylase deficiency: is prenatal diagnosis in a mother at risk essential? , 1987, Endokrynologia Polska.